middle.news
Orthocell Surpasses 100 US Sales of Remplir™, Boosting Nerve Repair Market Presence
9:50am on Thursday 18th of December, 2025 AEDT
•
Healthcare
Read Story
Orthocell Surpasses 100 US Sales of Remplir™, Boosting Nerve Repair Market Presence
9:50am on Thursday 18th of December, 2025 AEDT
Key Points
100 units of Remplir™ sold in the US nerve repair market
17 hospital Value Analysis Committee approvals secured out of 61 submissions
Distributor network spans 25 states covering 40% of US population
Over 250 surgeons engaged through medical education programs
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Orthocell (ASX:OCC)
OPEN ARTICLE